← Back to Screener
YD Bio Limited Warrants (YDESW)
Price$0.35
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-63.64%
Price vs S&P 500 (4W)-38.59%
VGM Score18.47
All Metrics
Price vs S&P 500 (YTD)-70.96%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.01M
52-Week High$2.85
26-Week Price Return-55.72%
13-Week Price Return-57.83%
3-Month Return Std Dev134.62%
Year-to-Date Return-64.65%
5-Day Price Return-4.11%
Month-to-Date Return-2.78%
Price vs S&P 500 (13W)-66.09%
Beta1.22x
52-Week Low$0.17
mGradeF
vgmGradeF
Show chart for
Industry Peers — Health Services(28)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
YDESWYD Bio Limited Warrants | — | — | F | $0.35 |
| NTRANatera, Inc. Common Stock | F | A | C | $215.31 |
| DGXQuest Diagnostics Inc. | C | D | C | $200.29 |
| LHLabcorp Holdings Inc. | C | D | C | $265.15 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| GHGuardant Health, Inc. Common Stock | F | A | B | $125.61 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | D | $16.49 |
| CELCCelcuity Inc. Common Stock | — | — | C | $88.28 |
| RDNTRadNet, Inc. Common Stock | D | C | C | $54.34 |
| VCYTVeracyte, Inc. | D | A | B | $48.73 |
| GRALGRAIL, Inc. Common Stock | D | A | C | $59.98 |
About
YD Bio Ltd is a biopharmaceutical company developing diagnostic and therapeutic solutions, including blood-based cancer detection tests and stem cell- and exosome-based therapeutics for diseases with significant unmet medical needs. The company also supplies clinical testing drugs to pharmaceutical companies.